David Marguglio
Net worth: 178 $ as of 2024-03-30
Profile
David J.
Marguglio is the founder of two companies.
In 2006, he founded Adamis Pharmaceuticals Corp.
where he held the title of Director & Vice President-Business Development from 2006 to 2009.
In the same year, he also founded DMK Pharmaceuticals Corp.
where he held the titles of President, CFO, COO & Secretary in 2023.
Mr. Marguglio's former jobs include being a Vice President at Merrill Lynch & Co., Inc. from 1996 to 2000 and a Vice President at Citigroup Global Markets, Inc. from 2000 to 2006.
Mr. Marguglio's education history includes an undergraduate degree from Hankamer School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-10-05 | 3,425 ( 0.03% ) | 178 $ | 2024-03-30 |
Former positions of David Marguglio
| Companies | Position | End |
|---|---|---|
| DMK PHARMACEUTICALS CORPORATION | Chief Executive Officer | 2023-05-24 |
Adamis Pharmaceuticals Corp. /Old/
 Adamis Pharmaceuticals Corp. /Old/ Pharmaceuticals: MajorHealth Technology Adamis Pharmaceuticals Corp. manufactures and markets pharmaceutical products. It develops technology for the prevention of viral infections such as avian flu. It markets and sells prescription products for a variety of allergy, respiratory diseases, and pediatric conditions. The company was founded in June 2006 and is headquartered in San Deigo, CA. | Founder | 2009-04-21 |
Citigroup Global Markets, Inc.
 Citigroup Global Markets, Inc. Investment Banks/BrokersFinance Citigroup Global Markets, Inc. engages in the provision of brokerage, investment banking, and asset management services to individuals, businesses, and governments. The company was founded by Julie E. Silcock and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Merrill Lynch & Co., Inc. /Old/
 Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch & Co., Inc. provided wealth management, securities trading and sales, corporate finance and investment banking services. Merrill Lynch was a global trader and underwriter of securities and derivatives across a range of asset classes and serve as a strategic advisor to governments, institutions and individuals worldwide. The company was founded in 1913 and was headquartered in Charlotte, NC. | Corporate Officer/Principal | 1999-12-31 |
Training of David Marguglio
| Hankamer School of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DMK PHARMACEUTICALS CORPORATION | Health Technology |
| Private companies | 3 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch & Co., Inc. provided wealth management, securities trading and sales, corporate finance and investment banking services. Merrill Lynch was a global trader and underwriter of securities and derivatives across a range of asset classes and serve as a strategic advisor to governments, institutions and individuals worldwide. The company was founded in 1913 and was headquartered in Charlotte, NC. | Finance |
Citigroup Global Markets, Inc.
Citigroup Global Markets, Inc. Investment Banks/BrokersFinance Citigroup Global Markets, Inc. engages in the provision of brokerage, investment banking, and asset management services to individuals, businesses, and governments. The company was founded by Julie E. Silcock and is headquartered in New York, NY. | Finance |
Adamis Pharmaceuticals Corp. /Old/
Adamis Pharmaceuticals Corp. /Old/ Pharmaceuticals: MajorHealth Technology Adamis Pharmaceuticals Corp. manufactures and markets pharmaceutical products. It develops technology for the prevention of viral infections such as avian flu. It markets and sells prescription products for a variety of allergy, respiratory diseases, and pediatric conditions. The company was founded in June 2006 and is headquartered in San Deigo, CA. | Health Technology |
- Stock Market
- Insiders
- David Marguglio
